GlycoMimetics to Present at Four Investor Conferences This Month
30th Annual
CFO
Cowen 38th Annual
CEO
BioCentury: 25th Annual Future Leaders in
the BioTech Industry
Mrs. King will
present in room 311 at
Needham & Company’s 17th Annual
HealthCare Conference
Mrs. King will present on
About
GlycoMimetics is a clinical-stage biotechnology company focused on the
discovery and development of novel glycomimetic drugs to address unmet
medical needs resulting from diseases in which carbohydrate biology
plays a key role.
View source version on businesswire.com: http://www.businesswire.com/news/home/20180307005331/en/
Source:
For GlycoMimetics, Inc.
Investors:
Shari Annes,
650-888-0902
sannes@annesassociates.com
or
Media:
Jamie
Lacey-Moreira, 410-299-3310
jamielacey@presscommpr.com